Uncategorized
Parallel trials show aflibercept superior to laser in DME treatment
HAMBURG — Results of two phase III multicentered trials, first disclosed here at the Euretina meeting, showed superior efficacy of aflibercept compared to conventional laser photocoagulation in the treatment of diabetic macular edema. The two studies, VISTA-DME and VIVID-DME, involved 54 centers in the United States and 73 centers in Europe, Japan and Australia and included 865 patients.